Human KRT16(Keratin 16) ELISA Kit

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 16 (KRT16) in serum, plasma, tissue homogenates and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 16 (KRT16) in serum, plasma, tissue homogenates and other biological fluids.

Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 16 (KRT16) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Description: Recombinant Human Keratin 16 expressed in: E.coli

Description: A sandwich ELISA kit for detection of Keratin 16 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16)

Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with APC.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with Biotin.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with Cy3.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with FITC.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with HRP.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with PE.

Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 16 (KRT16) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 16 (KRT16) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 16 (KRT16) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Description: A Mouse monoclonal antibody against Human Keratin 16 (KRT16). This antibody is labeled with APC-Cy7.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16)

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with APC.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with Biotin.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with Cy3.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with FITC.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with HRP.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with PE.

Description: A Rabbit polyclonal antibody against Human, Mouse, Rat Keratin 16 (KRT16). This antibody is labeled with APC-Cy7.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratin 16 is an epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. [UniProt]

Description: Cytokeratin 16 is an epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. [UniProt]

Description: Cytokeratin 16 is an epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. [UniProt]

Description: Cytokeratin 16 is an epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. [UniProt]

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Cytokeratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I Cytokeratins (Cytokeratins 9 to 23) and one type II Cytokeratins (keratins 1 to 8). The cytokeratin proteins play a critical role in differentiation, as well as tissue specialization and function, to maintain the overall structural integrity of epithelial cells. Cytokeratins are also useful markers in identifying the origin of metastatic tumors. Cytokeratin 16 is expressed in benign stratified squamous epithelium and squamous cell carcinoma of the head and neck, as well as luminal cells of mammary gland and sweat ducts. It is absent in non-invasive breast carcinomas and normal breast tissue.

Description: Disposable Culture Tubes; DCT's, CGW

Description: ELISA kit for the detection of Nucleo 9 Line 16 in the research laboratory

Description: KRT16 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 496 amino acids (1-473) and having a molecular mass of 53.7 kDa.;KRT16 is fused to a 23 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Description: ELISA kit for the detection of ANA 9 Line Immunoblot 16 in the research laboratory

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Concentration: 0.2mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), 1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Concentration: 0.2mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (KRT16/2043R), CF770 conjugate, Concentration: 0.1mg/mL

Description: Rabbit polyclonal Keratin 16 antibody

Description: Rabbit Polyclonal Keratin 16 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

Description: Description of target: Epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL

Description: Description of target: The protein encoded by this gene is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains and are clustered in a region of chromosome 17q12-q21. This keratin has been coexpressed with keratin 14 in a number of epithelial tissues, including esophagus, tongue, and hair follicles. Mutations in this gene are associated with type 1 pachyonychia congenita, non-epidermolytic palmoplantar keratoderma and unilateral palmoplantar verrucous nevus.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.064 ng/mL

Description: Description of target: KRT16 is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains and are clustered in a region of chromosome 17q12-q21. This keratin has been coexpressed with keratin 14 in a number of epithelial tissues, including esophagus, tongue, and hair follicles.The protein encoded by this gene is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains and are clustered in a region of chromosome 17q12-q21. This keratin has been coexpressed with keratin 14 in a number of epithelial tissues, including esophagus, tongue, and hair follicles. Mutations in this gene are associated with type 1 pachyonychia congenita, non-epidermolytic palmoplantar keratoderma and unilateral palmoplantar verrucous nevus. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.064ng/mL

Description: Corning and Axygen Liquid Handling Equipment; Axypet Pipettors and Motopet Pipet Controller

Description: Description of target: ;Species reactivity: Human, Mouse, Rat;Application: ELISA;Assay info: Assay Type: Cell-Based
Subtype: None
Detection Method: Colorimetric 450 nm;Sensitivity:

Description: Disposable Screw Cap Culture Tubes; DSCCT's, Lab Stock

Description: Disposable Screw Cap Culture Tubes; DSCCT's, Lab Stock

Description: ELISA based test for quantitative detection of T4 (Thyroxine)

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KRT16 / CK16 / Cytokeratin 16 (aa421-470). This antibody is tested and proven to work in the following applications:

Description: Description of target: Epidermis-specific type I keratin that plays a key role in skin.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078 ng/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Concentration: 0.2mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), 1mg/mL

Description: Primary antibody against Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), Concentration: 0.2mg/mL

Description: Corning and Axygen Liquid Handling Equipment; Axypet Pipettors and Motopet Pipet Controller

Description: Corning and Axygen Liquid Handling Equipment; Axypet Pipettors and Motopet Pipet Controller

Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 16, IL-16 in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 16, IL-16 in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml

Description: Rabbit polyclonal KRT16 antibody

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200

Description: A polyclonal antibody against KRT16. Recognizes KRT16 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

Description: A Monoclonal antibody against Human KRT16 / CK16 / Cytokeratin 16 (clone LL025). The antibodies are raised in Mouse and are from clone LL025. This antibody is applicable in IHC-P, IF